CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Syndax Pharmaceuticals prices $250M senior convertible notes

Positive
AI Analysis

Summary

Syndax Pharmaceuticals priced a $250 million offering of senior convertible notes to raise capital.

Importance:5/10
Sentiment:
0.30
capital_raiseconvertible_notesdebt_offering
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on June 4, 2026 11:35 AM

Read Original